Mitochondrial haplogroups associated with Japanese centenarians, Alzheimer's patients, Parkinson's patients, type 2 diabetic patients and healthy non-obese young males

Shigeru Takasaki

doi:10.1016/S1673-8527(08)60132-0

Volume 36 Issue 7

Jul. 2009

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2009 > 36(7): 425-434

PDF( 466 KB)

Mitochondrial haplogroups associated with Japanese centenarians, Alzheimer's patients, Parkinson's patients, type 2 diabetic patients and healthy non-obese young males

doi: 10.1016/S1673-8527(08)60132-0

Shigeru Takasaki

Toyo University, Izumino 1-1-1, Ouragun Itakuracho, Gunma 374-0193, Japan

More Information

Corresponding author: E-mail address: takasaki@khh.biglobe.ne.jp (Shigeru Takasaki)
Received Date: 2008-11-19
Accepted Date: 2009-03-10
Rev Recd Date: 2009-03-04

Available Online: 2009-07-23

Publish Date: 2009-07-20

Abstract

Abstract

The relationships between five classes of Japanese people (i.e., 96 centenarians, 96 Alzheimer's disease (AD) patients, 96 Parkinson's disease (PD) patients, 96 type 2 diabetic (T2D) patients, and 96 healthy non-obese young males) and their mitochondrial single nucleotide polymorphism (mtSNP) frequencies at individual mtDNA positions of the entire mitochondrial genome were examined using the radial basis function (RBF) network and the modified method. New findings of mitochondrial haplogroups were obtained for individual classes. The five classes of people were associated with the following haplogroups: Japanese centenarians—M7b2, D4b2a, and B5b; Japanese AD patients—G2a, B4c1, and N9b1; Japanese PD patients—M7b2, B4e, and B5b; Japanese T2D patients—B5b, M8a1, G, D4, and F1; and Japanese healthy non-obese young males— D4g and D4b1b. From the points of common haplogroups among the five classes, the centenarians have the common haplogroups M7b2 and B5b with the PD patients and common haplogroup B5b with the T2D patients. In addition, the 112 Japanese semi-supercentenarians (over 105 years old) recently reported were also examined by the method proposed. The results obtained were the haplogroups D4a, B4c1a, M7b2, F1, M1, and B5b. These results are different from the previously reported haplogroup classifications. As the proposed analysis method can predict a person's mtSNP constitution and the probabilities of becoming a centenarian, AD patient, PD patient, or T2D patient, it may be useful in initial diagnosis of various diseases.
- mtSNPs,
- haplogroup,
- semi-supercentenarians,
- centenarians,
- Alzheimer's disease,
- Parkinson's disease,
- type 2 diabetic patients,
- healthy non-obese young males,
- radial basis function (RBF)

FullText(HTML)

References(29)

References

[1]	Alexe, G., Fuku, N., Bilal, E. et al. Enrichment of longevity phenotype in mtDNA haplogroups D4b2b, D4a, and D4 in the Japanese population Hum. Genet., 121 (2007),pp. 347-356
[2]	Bilal, E., Rabadan, R., Alexe, G. et al. Mitochondrial DNA haplogroup D4a is a marker for extreme longevity in Japan PLoS ONE, 3 (2008),p. e2421
[3]	Chinnery, P.F., Mowbray, C., Patel, S.K. et al. Mitochondrial DNA haplogroups and type 2 diabetes: A study of 897 cases and 1010 controls J. Med. Genet., 44 (2008),p. e80
[4]	Dawson, T.M., Dawson, V.L. Molecular pathway of neurodegeneration in Parkinson's disease Science, 302 (2003),pp. 819-822
[5]	Fuku, N., Park, K.S., Yamada, Y. et al. Mitochondrial haplogroup N9a confers resistance against Type 2 diabetes in Asians Am. J. Hum. Genet., 80 (2007),pp. 407-415
[6]	Feder, J., Blech, I., Ovadia, O. et al. Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications BMC Genomics, 9 (2008),p. 198
[7]	Herrnstadt, C., Elson, J.L., Fahy, E. et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian and European haplogroups Am. J. Hum. Genet., 70 (2002),pp. 1152-1171
[8]	Kim, W., Yoo, T.K., Shin, D.J. et al. Mitochondrial haplogroup analysis reveals no association between the common genetic lineages and prostate cancer in the Korean population PLoS ONE, 3 (2008),p. e2211
[9]	Kosel, S., Egensperger, R., Mehraein, P. et al. No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease Biochem. Biophys. Res. Commun., 203 (1994),pp. 745-749
[10]	Kong, Q.P., Yao, Y.G., Sun, C. et al. Phylogeny of East Asian mitochondrial DNA lineages inferred from complete sequences Am. J. Hum. Genet., 73 (2003),pp. 671-676
[11]	Kong, Q.P., Salas, A., Sun, C. et al. Distilling artificial recombinants from large sets of complete mtDNA genomes PLoS ONE, 3 (2008),p. e3016
[12]	Lin, F., Lin, R., Wisniewski, H.M. et al. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains Biochem. Biophys. Res. Commun., 182 (1992),pp. 238-246
[13]	Lustbader, J.W., Cirilli, M., Lin, C. et al. ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease Science, 304 (2004),pp. 448-452
[14]	Mayr-Wohlfart, U., Paulus, C., Rodel, G. Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement Acta Neurol. Scand., 94 (1996),pp. 167-171
[15]	Maruszak, A., Canter, J.A., Styczynska, M. et al. Mitochondrial haplogroup H and Alzheimer's disease—Is there a connection? Neurobiol. Aging (2008)
[16]	Niemi, A.K., Moilanen, J.S., Tanaka, M. et al. A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects Eur. J. Hum. Genet., 13 (2005),pp. 166-170
[17]	Poggio, T., Girosi, F. Networks for approximation and learning Proc. IEEE, 78 (1990),pp. 1481-1497
[18]	Ross, O.A., MaCormack, R., Maxwell, L.D. et al. mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish Exp. Gerontol., 38 (2003),pp. 397-405
[19]	Saxena, R., de Bakker, P.I., Singer, K. et al. Comprehensive association testing of common mitochondrial DNA variation in metabolic disease Am. J. Hum. Genet., 79 (2006),pp. 54-61
[20]	Schoffner, J.M., Brown, M.D., Torroni, A. et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients Genomics, 17 (1993),pp. 171-184
[21]	Schnopp, N.M., Kosel, S., Egensperger, R. et al. Regional heterogeneity of mtDNA hetroplasmy in parkinsonian brain Clin. Neuropathol., 15 (1996),pp. 348-352
[22]	Simon, D.K., Mayeux, R., Marder, K. et al. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease Neurology, 54 (2000),pp. 703-709
[23]	Tanaka, M., Fuku, N., Takeyasu, T. et al. J. Neurosci. Res., 70 (2002),pp. 347-355
[24]	Tanaka, M., Cabrera, V.M., Gonzalez, A.M. et al. Mitochondrial genome variation in Eastern Asia and the peopling of Japan Genome Res., 14 (2004),pp. 1832-1850
[25]	Takasaki, S., Kawamura, Y., Konagaya, A. Selecting effective siRNA sequences by using radial basis function network and decision tree learning BMC Bioinformatics, 7 (2006),p. S22
[26]	Taylor, R.W., Turnbull, D.M. Mitochondrial DNA mutations in human disease Nat. Rev. Genet., 6 (2005),pp. 389-402
[27]	Vila, M., Przedborski, S. Targeting programmed cell death neurodegenerative diseases Nat. Rev. Neurosci., 4 (2003),pp. 1-11
[28]	Wallace, D.C. Mitochondrial diseases in man and mouse Science, 283 (1999),pp. 1482-1488
[29]	Wu, C.H., McLarty, J.W.